Prostate Cancer Vaccine Developed by Advantagene

Prostate Cancer Vaccine Developed by Advantagene
There is a 30% chance of cancer recurrence in patients diagnosed with high-risk prostate cancer. Even after a patient has undergone radiation therapy and considered cancer free, the malignancy still has the potential to come back. “A recurrence is what no prostate cancer survivor wants to hear. Because when you have a recurrence of disease

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *